Add to ORKGClinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNFa and IL18 but not CXCL1
BACKGROUND: Not all patients with rheumatoid arthritis can tolerate or respond to methotrexate, a st...
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versu...
Contains fulltext : 141883.pdf (publisher's version ) (Open Access)Tumor necrosis ...
Item does not contain fulltextThe current pharmacotherapy of rheumatoid arthritis (RA) consists of n...
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared w...
1 Title: The efficacy and toxicity of methotrexate (MTX) monotherapy vs. MTX combination therapy wit...
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) has been inducted as a mediator of inflamm...
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthrit...
Objective: To determine whether the heterogeneous clinical response to tumour necrosis factor (TNF)a...
Tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) are important in mediating inflamma...
Golimumab, a human antibody to tumour necrosis factor a given by monthly subcutaneous injections, in...
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with meth...
Many studies have confirmed that the long term use of biological agents targeting TNFalpha in therap...
Many studies have confirmed that the long term use of biological agents targeting TNFalpha in therap...
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tum...
BACKGROUND: Not all patients with rheumatoid arthritis can tolerate or respond to methotrexate, a st...
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versu...
Contains fulltext : 141883.pdf (publisher's version ) (Open Access)Tumor necrosis ...
Item does not contain fulltextThe current pharmacotherapy of rheumatoid arthritis (RA) consists of n...
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared w...
1 Title: The efficacy and toxicity of methotrexate (MTX) monotherapy vs. MTX combination therapy wit...
Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) has been inducted as a mediator of inflamm...
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthrit...
Objective: To determine whether the heterogeneous clinical response to tumour necrosis factor (TNF)a...
Tumor necrosis factor alpha (TNF alpha) and interleukin-1 (IL-1) are important in mediating inflamma...
Golimumab, a human antibody to tumour necrosis factor a given by monthly subcutaneous injections, in...
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with meth...
Many studies have confirmed that the long term use of biological agents targeting TNFalpha in therap...
Many studies have confirmed that the long term use of biological agents targeting TNFalpha in therap...
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tum...
BACKGROUND: Not all patients with rheumatoid arthritis can tolerate or respond to methotrexate, a st...
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versu...
Contains fulltext : 141883.pdf (publisher's version ) (Open Access)Tumor necrosis ...